IDS Business Integrator, GPOs
BIOGRAPHY
MAR 30, 2021 11:00 AM PDT
Getting to know your BD Veritor™ System for Rapid Detection of SARS-CoV-2
Speakers
-
Chris Girard
BD Product Manager, Point of CareBIOGRAPHY
Event Date & Time
Date: March 30, 2021
Time: 11:00am (PDT), 2:00pm (EDT)
Abstract
As the world continues to have a need for COVID-19 testing, BD offers a reliable rapid antigen COVID-19 testing solution through the BD Veritor™ System for Rapid Detection of SARS-CoV-2*. This presentation will provide an overview of the role of antigen testing, review what the BD Veritor™ System for Rapid Detection of SARS-CoV-2, demonstration how to use the device and review the available educational resources for you and your staff.
Learning Objectives
- To review and understand the role of rapid antigen testing for SARS-CoV-2
- To learn about the BD Veritor™ System for Rapid Detection of SARS-CoV-2
- To learn how to perform a COVID-19 test using the BD Veritor™ System for Rapid Detection of SARS-CoV-2
*This product has not been FDA cleared or approved; but has been authorized by FDA under an Emergency Use Authorization for use by authorized laboratories. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...